Abstract
Rare diseases are a significant healthcare challenge, affecting over 300 million people worldwide across more than 7,000 conditions, most of which manifest in childhood and have a severe chronic course. In May 2025, the World Health Assembly adopted WHO Resolution WHA78.11, formally recognizing rare diseases as a global health priority. This review aims to analyze the key provisions of the resolution and their implementation in countries with different healthcare models: France, Japan, Brazil, and Saudi Arabia.Data were collected from official governmental and international sources, scientific publications, and analytical reports from 2018 to 2025. The analysis shows that sustainable development of rare disease care systems requires the development and implementation of national strategies and plans, the establishment of centers of expertise, the advancement of digitalinfrastructure, the integration of real-world data, and the application of innovative financing mechanisms, including managed entry agreements and outcome-based payment models. The findings may inform national approaches tailored to the local context.